Wilsele, Belgium

Joris Winderickx

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Joris Winderickx: Innovator in Neurodegeneration Research

Introduction

Joris Winderickx is a notable inventor based in Wilsele, Belgium. He has made significant contributions to the field of neurodegeneration, particularly in relation to tau-related diseases and tauopathy. His innovative work has led to the development of valuable tools for research and diagnosis in this critical area of health.

Latest Patents

Winderickx holds a patent for "Antibodies to phosphorylated tau aggregates." This invention focuses on affinity tools for oligomeric forms of tau protein. It provides novel tau antibodies and antibody fragments, nucleic acids encoding such antibodies, and cell lines producing these antibodies. Additionally, the invention includes antibody compositions and kits for the detection of aggregated tau, as well as methods for diagnosing diseases involving aggregated tau. This work is crucial for identifying compositions that can interfere with the formation and stability of tau aggregates.

Career Highlights

Throughout his career, Winderickx has worked with several esteemed organizations. He has been associated with Katholieke Universiteit Leuven, where he contributed to academic research. He also worked with Ku Research & Development and Fujirebio Europe N.V., further enhancing his expertise in the field.

Collaborations

Winderickx has collaborated with notable colleagues, including Eugeen Vanmechelen and Fred Van Leuven. These partnerships have enriched his research and contributed to advancements in understanding tau-related diseases.

Conclusion

Joris Winderickx's innovative work in developing antibodies for tau aggregates represents a significant advancement in neurodegeneration research. His contributions are vital for the diagnosis and understanding of tau-related diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…